Daniel R. Faga
2018
In 2018, Daniel R. Faga earned a total compensation of $2.5M as Chief Business Officer at Spark Therapeutics, a 15% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $198,660 |
|---|---|
| Option Awards | $1,207,472 |
| Salary | $430,867 |
| Stock Awards | $505,500 |
| Other | $204,410 |
| Total | $2,546,909 |
Faga received $1.2M in option awards, accounting for 47% of the total pay in 2018.
Faga also received $198.7K in non-equity incentive plan, $430.9K in salary, $505.5K in stock awards and $204.4K in other compensation.
Rankings
In 2018, Daniel R. Faga's compensation ranked 4,584th out of 14,244 executives tracked by ExecPay. In other words, Faga earned more than 67.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,584 out of 14,244 | 68th |
Division Manufacturing | 1,717 out of 5,759 | 70th |
Major group Chemicals And Allied Products | 618 out of 2,122 | 71st |
Industry group Drugs | 517 out of 1,811 | 72nd |
Industry Biological Products, Except Diagnostic Substances | 103 out of 339 | 70th |
Pay ratio
| Daniel R. Faga's Pay | $2,546,909 |
|---|---|
| Median Employee's Pay | $182,200 |
| Pay Ratio | 14to 1 |
In 2018, the annual total compensation of Daniel R. Faga was $2,546,909.
The annual total compensation of the median employee at Spark Therapeutics was $182,200.
The ratio of Daniel R. Faga's pay to the pay of median employee was therefore 14 to one.
Source: SEC filing on July 22, 2019.
Faga's colleagues
We found four more compensation records of executives who worked with Daniel R. Faga at Spark Therapeutics in 2018.